Milestone Scientific (NYSE:MLSS) Now Covered by StockNews.com

StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS) in a report published on Thursday morning. The firm issued a hold rating on the stock.

Milestone Scientific Price Performance

MLSS opened at $0.65 on Thursday. The stock’s 50 day moving average price is $0.65 and its 200 day moving average price is $0.69. The stock has a market cap of $49.79 million, a P/E ratio of -6.50 and a beta of 0.94. Milestone Scientific has a 12 month low of $0.52 and a 12 month high of $1.35.

Milestone Scientific (NYSE:MLSS) last posted its quarterly earnings data on Friday, March 29th. The company reported ($0.03) EPS for the quarter. The firm had revenue of $2.26 million during the quarter. Milestone Scientific had a negative return on equity of 86.72% and a negative net margin of 70.50%.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Milestone Scientific stock. AE Wealth Management LLC purchased a new stake in Milestone Scientific Inc. (NYSE:MLSS) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 27,936 shares of the company’s stock, valued at approximately $26,000. 5.79% of the stock is owned by institutional investors.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.